We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $201M
1-Year Est. Return 21.29%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$197M
AUM Growth
+$20.3M
Cap. Flow
-$363K
Cap. Flow %
-0.18%
Top 10 Hldgs %
15.03%
Holding
148
New
5
Increased
49
Reduced
78
Closed
3

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$329K
2
CBRE icon
CBRE Group
CBRE
+$300K
3
CRM icon
Salesforce
CRM
+$239K
4
LRCX icon
Lam Research
LRCX
+$238K
5
GPC icon
Genuine Parts
GPC
+$199K

Sector Composition

Rank Sector Weight
1 Healthcare 18.97%
2 Technology 15.68%
3 Industrials 15.57%
4 Consumer Staples 14.39%
5 Consumer Discretionary 12.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$3.3M 1.68%
6,229
-89
-1% -$47.1K
ADM icon
2
Archer Daniels Midland
ADM
$41.4B
$3.3M 1.68%
35,498
-201
-0.6% -$18.6K
TMO icon
3
Thermo Fisher Scientific
TMO
$211B
$3.04M 1.55%
5,529
+18
+0.3% +$9.54K
AFL icon
4
Aflac
AFL
$63.9B
$2.96M 1.51%
41,178
-990
-2% -$66.3K
PEP icon
5
PepsiCo
PEP
$186B
$2.91M 1.48%
16,083
-79
-0.5% -$14.1K
COST icon
6
Costco
COST
$415B
$2.87M 1.46%
6,284
-73
-1% -$35.7K
SYK icon
7
Stryker
SYK
$127B
$2.81M 1.43%
11,487
-21
-0.2% -$4.76K
GWW icon
8
W.W. Grainger
GWW
$65.3B
$2.81M 1.43%
5,046
-109
-2% -$61.5K
AAPL icon
9
Apple
AAPL
$4.89T
$2.79M 1.42%
21,444
-73
-0.3% -$10.4K
ITW icon
10
Illinois Tool Works
ITW
$81.4B
$2.76M 1.41%
12,545
-101
-0.8% -$21.5K
APD icon
11
Air Products & Chemicals
APD
$66.3B
$2.76M 1.4%
8,956
+226
+3% +$63.7K
CVX icon
12
Chevron
CVX
$388B
$2.75M 1.4%
15,301
-776
-5% -$135K
PG icon
13
Procter & Gamble
PG
$343B
$2.71M 1.38%
17,909
+8
+0% +$1.12K
ORCL icon
14
Oracle
ORCL
$331B
$2.7M 1.37%
32,993
-115
-0.3% -$8.74K
JPM icon
15
JPMorgan Chase
JPM
$939B
$2.69M 1.37%
20,020
+239
+1% +$30.3K
ORLY icon
16
O'Reilly Automotive
ORLY
$72.4B
$2.66M 1.35%
47,295
-2,745
-5% -$148K
EMR icon
17
Emerson Electric
EMR
$82.9B
$2.64M 1.34%
27,443
-176
-0.6% -$15.8K
V icon
18
Visa
V
$677B
$2.63M 1.34%
12,682
+41
+0.3% +$8.27K
DHR icon
19
Danaher
DHR
$135B
$2.57M 1.31%
10,936
+456
+4% +$106K
AMGN icon
20
Amgen
AMGN
$203B
$2.54M 1.29%
9,659
-37
-0.4% -$9.92K
APH icon
21
Amphenol
APH
$188B
$2.54M 1.29%
66,650
-706
-1% -$26.7K
WMT icon
22
Walmart Inc
WMT
$871B
$2.51M 1.28%
53,139
+660
+1% +$31.3K
ADP icon
23
Automatic Data Processing
ADP
$100B
$2.51M 1.28%
10,508
-230
-2% -$56.5K
MCD icon
24
McDonald's
MCD
$188B
$2.5M 1.27%
9,502
-161
-2% -$42.5K
FISV
25
Fiserv Inc
FISV
$27.2B
$2.48M 1.26%
24,498
+385
+2% +$38.3K

Similar funds

Eads & Heald Wealth Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eads & Heald Wealth Management held 148 positions worth $197M, up 12% from $176M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2022 filing shows 5 new, 49 increased, 78 reduced and 3 closed positions. Its largest new stake was Charles River Laboratories: 2,851 shares worth $621K. The largest sale was Verisk Analytics, an estimated $329K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2022 buy was Charles River Laboratories: 2,851 shares worth $621K.
  • Eads & Heald Wealth Management added most to Crown Holdings in Q4 2022, an estimated $380K increase.
  • Eads & Heald Wealth Management's biggest Q4 2022 reduction was Verisk Analytics, cutting an estimated $329K.
  • Eads & Heald Wealth Management fully exited Cleveland-Cliffs in Q4 2022, selling an estimated $199K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $197M portfolio in Q4 2022.
  • Eads & Heald Wealth Management opened 5 new positions and closed 3 in Q4 2022.
  • Eads & Heald Wealth Management's portfolio value rose 12% quarter-over-quarter to $197M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2022, filed 27 Jan 2023.